Indeed, treatment of MM cells/BMSCs co-cultures with YM155, a small molecule that inhibits survivin expression, increased Dara-mediated ADCC abrogating the protective role of BM microenvironment against Dara treatment [68]. This evidence concerns the gene BIRC5 and Miyoshi myopathy.